Replimune Group, Inc. Form 8-K Summary
Business context and reporting period
Replimune Group, Inc. filed a Form 8-K dated September 6, 2023, reporting the results of its annual meeting of stockholders held that day. The filing concerns corporate governance matters rather than operating or financial results.
Key financial and operating metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.
Material changes versus the prior comparable period
- No material financial or operating changes are reported.
- Paolo Pucci and Veleka Peeples-Dyer were elected as Class II directors for three-year terms ending at the 2026 annual meeting, subject to the election and qualification of their successors.
- Stockholders ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2024.
Guidance, outlook, risks, contingencies, and unusual items
The filing provides no financial guidance, business outlook, risk update, contingencies, or unusual items. Voting results included broker non-votes of 5,424,721 for each director nominee.
Most important facts to verify
- Paolo Pucci: 25,146,894 votes for, 21,307,605 withheld, and 5,424,721 broker non-votes.
- Veleka Peeples-Dyer: 43,195,979 votes for, 3,258,520 withheld, and 5,424,721 broker non-votes.
- Auditor ratification: 51,869,761 votes for, 4,084 against, and 5,375 abstaining.
- The filing text does not provide a clear value for any financial performance or liquidity measure.